Tuesday, July 1, 2025 7/1/2025

New approaches for leveraging single-cell data to identify disease-critical genes and gene sets

Award Number: R00HG012203
ORGANIZATION: NATIONAL HUMAN GENOME RESEARCH INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/10/2023
PERIOD OF PERFORMANCE END DATE: 02/28/2026

Group Awards By:

View Award Description

New approaches for leveraging single-cell data to identify disease-critical genes and gene sets - PROJECT SUMMARY/ABSTRACT Nominating candidate risk genes and gene sets underlying disease-critical processes is of utmost importance for developing drug targets and informing CRISPR screening experiments. To this end, large scale single-cell genomic and epigenomic data (from RNA-seq, ATAC-seq, Perturb-seq) can be integrated with genome wide association studies (GWAS) to enhance our understanding of the genetic architecture of human complex diseases and traits. In this proposal, I plan to develop new computational approaches to integrate single- cell functional genomic and epigenomic data with GWAS data for complex diseases and traits to identify and rank disease-critical genes and gene sets characterizing functional processes, as well as pinpoint short genomic regions linked to these disease-associated genes. My K99 training will be conducted at the Harvard T.H. Chan School of Public Health, as well as the Broad Institute, under the mentorship of Dr. Alkes Price. The key areas of my training will be to develop and evaluate approaches for gene-level and gene set-level functional architecture of diseases and traits and integrative analysis of single-cell, as well as bulk, functional genomics data with human disease genetics. My proposed approaches will attempt to bridge the gap between functional genomics and human genetics and downstream clinical drug/gene intervention experiments. The long- term goal of this research is to produce a set of computational tools that identify and rank top disease-critical genes, top disease-critical gene sets characterizing cell types or cellular processes and gene-linked genomic regions for each disease/trait. These approaches will reshape our understanding of the functional architecture of human diseases at cellular level and will inform future drug perturbation and CRISPR screening experiments. The first aim of this proposal is to develop methods to identify and rank disease-critical genes by integrating common and rare variant disease associations with gene-level functional information derived from single-cell genomics experiments. Here I will develop, compare and contrast multiple gene prioritization strategies that differ in how they annotate SNPs for a gene, how they aggregate variant level associations at gene level and how they use functional data in performing the gene prioritization. The second aim of this proposal is to develop new computational strategies to assess disease information in sets of genes that underlie a cell type or cellular processes active within or across cell types in a tissue. The third aim of this proposal is to pinpoint and prioritize short genomic regions that are either proximally or functionally linked (for example, as an enhancer) to disease- critical genes and gene sets from Aims 1 and 2. Here, I plan to integrate GWAS association signal near these gene-linked regions with deep learning models that can infer allelic effects at base pair resolution and single-cell ATAC-seq data. All disease-critical genes, gene sets and gene-linked regions along with relevant computational tools will be distributed publicly to the scientific community.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $249,000 )
2025	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Human Genome Research	000	5	3/6/2025	NON-COMPETING CONTINUATION	$224,101
2025	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Human Genome Research	001	5	4/29/2025	NON-COMPETING CONTINUATION	$24,899
														Subtotal = $249,000

Issue Date FY: 2024 ( Subtotal = $259,612 )
2024	2024	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Human Genome Research	002	4	8/7/2024	NON-COMPETING CONTINUATION	$19,919
2024	2024	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVENUE	NEW YORK	NY	10065	NEW YORK	USA	Human Genome Research	001	4	3/13/2024	NON-COMPETING CONTINUATION	$224,101
2024	2024	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Human Genome Research	003	4	9/4/2024	NON-COMPETING CONTINUATION	$4,980
2024	2023	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Human Genome Research	000	3	12/11/2023	EXTENSION WITH OR WITHOUT FUNDS	$10,612
														Subtotal = $259,612

Issue Date FY: 2023 ( Subtotal = $249,000 )
2023	2023	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Human Genome Research	000	3	3/10/2023	EXTENSION WITH OR WITHOUT FUNDS	$249,000
														Subtotal = $249,000

Grand Total All Awards = $757,612

Top

All Categories

About

Search

Reports

Data Submission

Award Information

New approaches for leveraging single-cell data to identify disease-critical genes and gene sets

Award Number: R00HG012203

ORGANIZATION: NATIONAL HUMAN GENOME RESEARCH INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/10/2023

PERIOD OF PERFORMANCE END DATE: 02/28/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer